Home » Isis, Excaliard Collaborate to Develop Antisense Drugs for Fibrotic Diseases
Isis, Excaliard Collaborate to Develop Antisense Drugs for Fibrotic Diseases
Isis Pharmaceuticals, Inc. and Excaliard Pharmaceuticals, Inc. announced a new collaboration to discover and develop antisense drugs for the local treatment of fibrotic diseases, including scarring.
FreshNews.com
FreshNews.com
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May